Indiana University Melvin and Bren Simon Cancer Center ( Site 4011) — Indianapolis, Indiana

Indiana University Melvin and Bren Simon Cancer Center ( Site 4011) is a clinical research site located in Indianapolis, Indiana, United States 46202.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Indiana University Melvin and Bren Simon Cancer Center ( Site 4011) has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Metastatic Urothelial Carcinoma, Locally Advanced Urothelial Carcinoma.

Sponsors: Merck Sharp & Dohme LLC.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Indiana University Melvin and Bren Simon Cancer Center ( Site 4011)?

Indiana University Melvin and Bren Simon Cancer Center ( Site 4011) has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Indiana University Melvin and Bren Simon Cancer Center ( Site 4011) conducted?

Indiana University Melvin and Bren Simon Cancer Center ( Site 4011) has 1 clinical trials on record, with 1 currently active. Their work covers Metastatic Urothelial Carcinoma, Locally Advanced Urothelial Carcinoma.

Is Indiana University Melvin and Bren Simon Cancer Center ( Site 4011) accredited by Crixeo Health?

Indiana University Melvin and Bren Simon Cancer Center ( Site 4011) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Indiana University Melvin and Bren Simon Cancer Center ( Site 4011)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.